Methyl (S)-2-(Boc-amino) -3-[(S) -2-oxo-3-pyrrolidinyl] propanoate CAS 328086-60-8 PF-07321332 Boceprevir Intermediate

Takaitaccen Bayani:

Sunan Chemical: Methyl (S)-2-(Boc-amino) -3-[(S) -2-oxo-3-pyrrolidinyl] propanoate

Saukewa: 328086-60

Bayyanar: Fari zuwa Kashe-fari foda

Matsakaicin PF-07321332 Paxlovid (CAS 2628280-40-8) da Boceprevir (CAS 394730-60-0)

Kyakkyawan inganci, Samar da Kasuwanci

Inquiry: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Abubuwan Sinadarai:

Sunan Sinadari Methyl (S)-2-(Boc-amino)-3-[(S) -2-oxo-3-pyrrolidinyl] propanoate
Makamantu Methyl (S)-2-((tert-butoxycarbonyl)amino) -3-((S) -2-oxopyrrolidin-3-yl) propanoate;(αS,3S) -α- [(tert-Butyloxycarbonyl) aMino] -2-oxo-3-pyrrolidinepropanoic acid Methyl Ester;(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl) propanoate
Lambar CAS 328086-60-8
Lambar CAT Saukewa: RF-PI317
Matsayin Hannun jari A Hannun jari, Ma'aunin Samfuran Har zuwa Daruruwan Kilogram
Tsarin kwayoyin halitta Saukewa: C13H22N2O5
Nauyin Kwayoyin Halitta 286.33
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Fari zuwa Kashe-Farin Foda
Identification A IR: Mai kama da Abun Magana
Identity B Lokacin Tsayawa: Kama da Abun Magana
Asara akan bushewa ≤1.0%
Ragowa akan Ignition ≤0.20%
Tsaftace Guda Daya ≤0.50%
Jimlar ƙazanta ≤2.0%
Karfe masu nauyi (Pb) ≤20ppm
Tsafta ≥98.0%
Matsayin Gwaji Matsayin Kasuwanci
Amfani Matsakaicin PF-07321332 Paxlovid (CAS 2628280-40-8) da Boceprevir (CAS 394730-60-0)

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, Kwali drum, 25kg / Drum, ko bisa ga abokin ciniki ta bukata.

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske, danshi da kamuwa da kwari.

Amfani:

1

FAQ:

Aikace-aikace:

Methyl (S) -2- (Boc-amino) -3- [(S) -2-oxo-3-pyrrolidinyl] propanoate (CAS 328086-60-8) shine matsakaici na PF-07321332 Paxlovid (CAS 2628280-40) -8) da Boceprevir (CAS 394730-60-0).PF-07321332, babban ɓangaren Paxlovid (PF-07321332 da Ritonavir) wanda shine ɗan takarar bincike na COVID-19 na baka, shine mai hana 3C-kamar protease (3CLPRO) na baki tare da tasirin antiviral akan kwayar cutar SARS-CoV-2. da COVID-19.A ranar 6 ga Nuwamba, 2021, Pfizer ya ba da sanarwar cewa Paxlovid ya ragu sosai a asibiti da mutuwa, bisa ga wani bincike na wucin gadi na Mataki na 2/3 EPIC-HR (Kimanin Hana Protease don COVID-19 a cikin Marasa Lafiya Masu Haɗari) bazuwar, binciken makafi biyu. na manya marasa lafiya marasa asibiti tare da COVID-19, waɗanda ke cikin haɗarin ci gaba zuwa rashin lafiya mai tsanani.Boceprevir (EBP-520) shine mai hana HCV protease inhibitor (Ki=14 nM) don maganin kamuwa da cutar hanta.Boceprevir tare da pegylated interferon da ribavirin (PegIFN/RBV) sun ba da damar haɓakawa a cikin ƙimar amsawar ƙwayoyin cuta na marasa lafiya tare da genotype 1 HCV.Boceprevir yana hulɗa tare da maganin rigakafi (IT) ta hanyar hana cytochrome P450 3A enzyme.

Ku rubuta sakonku anan ku aiko mana